retatrutide approval Retatrutide, an experimental weight-loss drug, has not been approved by the FDA. But, doctors and nurse practitioners in clinics across the country are prescribing it anyway, a CBS News investigation found. @adamyamaguchi Retatrutide vs. Tirzepatide: The New

GLP-1 medications are synthetic versions designed to activate these same pathways more powerfully and persistently

Semaglutide works by mimicking the GLP-1 hormone, which helps regulate appetite and slows gastric emptying, promoting feelings of fullness for longer periods

Most telehealth clinics offer free initial consultations with their weight-loss programs as well as free lab work and home delivery of medication

Paying for a plan is not the same as receiving a prescription

Although the meta-analysis did not uniformly report indices such as HOMA-IR or fasting insulin, several included studies noted improvements in glucose homeostasis following weight loss

Semaglutide is unusual: it's on-patent, commercially available, and still legally compoundable due to shortage status